Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03127215
Title Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603)
Acronym NCT-PMO-1603
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Center for Tumor Diseases, Heidelberg
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.